WENCO-INTERNATIONAL
14.9.2022 05:01:37 CEST | Business Wire | Press release
Wenco International Mining Systems Ltd. ("Wenco") is pleased to expand its sales and support to customers in Northern Europe through its new partnership with Rotator Oy, a leading provider of mining equipment and solutions, based in Finland.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220913006133/en/
This new agreement extends Wenco’s reach with a capable value-added reseller, paving the way for customers in the region to further leverage Wenco’s open and interoperable approach to mining technology.
Wenco is a leading provider of technology solutions to the global mining industry with a comprehensive suite of digital solutions that boost productivity, decrease operating costs, extend equipment life, enhance safety, and give mining companies actionable insights into their operations. Mines realize these benefits through systems for fleet management, machine guidance, safety, and asset health — all grounded in an open systems philosophy that empowers them to freely integrate systems to support their unique business processes, data requirements, and reporting needs.
“We’re very positive about the establishment of this partnership with Rotator,” says Andrew Pyne, President and CEO of Wenco. “They have a very strong presence in the region and an excellent track record of sales and support for Hitachi Construction Machinery, our parent company. We’re looking forward to working closely with Rotator to deliver value through the application of our technologies to their customers in the region.”
Rotator CEO Janne Wartiovaara concurs with Pyne. “We are excited to add Wenco to our Mining offering and look forward to bring more valuable solutions to our customers,” says Janne Wartiovaara.
In addition to solutions for fleet operations, Rotator and Wenco are introducing innovative fatigue management solutions to the market with Wenco’s SmartCap, the only technology proven to eliminate safety incidents caused by fatigue. SmartCap uses EEG to measure operator fatigue, then notify users of reduced ability to resist sleep — before a fatigue-related incident occurs.
Wenco and Rotator formed this partnership due to their shared focus on delivering customer-centric solutions to the mining industry. Founded in 1954, Rotator is one of the most experienced and well-established machine import and after-sales service companies in Finland. Located in Pirkkala with satellite offices in Vantaa, Kuopio, Seinäjoki, Oulu, Rovaniemi, Sotkamo, and Lieto, Rotator is committed to providing reliable, efficient, and safe solutions to customers through Finland and Sweden.
The company’s rich history of support for customers made it a natural partner for Wenco in Northern Europe.
Rotator is now in discussions with mines across Finland and Sweden on how they can advance their digital transformation with Wenco’s solutions. To learn more, please contact Rotator Sales Manager Sami Laitila at sami.laitila@rotator.fi or +35840-8242-495. For all other inquiries into Wenco and its solutions, please contact Wenco Regional Manager Europe, Middle East, and Kazakhstan, Klaus Hansson at khansson@wencomine.com or +971-522-600-596.
About Wenco International Mining Systems
For over 30 years, Wenco International Mining Systems has worked with mining companies to extract unrealized value. In support of this mission, Wenco has developed an integrated suite of solutions to support the digital transformation of the mining industry. Fleet management, asset health, fatigue management, and other technologies join together in the spirit of open interoperability to raise mine productivity and efficiency, lower routine costs, and establish a safe and smooth mining operation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220913006133/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company7.5.2026 15:07:00 CEST | Press release
Initial planning calls for Data Sciences Division to focus efforts in cyber secure infrastructure with dedication in fintech and patented Information Data Exchange® (IDE®) Management will harness its API Media acquisition, robust patent portfolio, ADIO® Inaudible Tones, WiSA® and Dolby® partnerships to establish worldwide acoustic industry standards in high-definition wireless transmission, spatial-audio control and interoperability Plan includes API media’s stand-alone and renewed execution of WiSA semiconductor and software modules strategy with an R&D effort targeted to new robotic and drone applications Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today announced that Company management has commenced its evaluation of a potential dividend spin-out of the Company’s Acoustic Sciences division which includes its ADIO®, WiSA®, Event Citadel™,
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release
First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom